Journal rankings · indicator year 2015
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2015
Pulmonary and Respiratory Medicine journal rankings 2015
297 ranked journals · Subfield in Medicine
Pulmonary and Respiratory Medicine has 297 ranked journals in 2015. The median journal has an OJR of 0.73, below the world average of 1.00, down 0.02 on 2014; Q1 starts at OJR 1.31. The top three are European Urology, Cochrane Database of Systematic Reviews, and The Lancet Respiratory Medicine.
Ranks and citation indicators: 2015. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2012–2014, the window the 2015 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Medicine (42)
- Surgery773
- Pulmonary and Respiratory Medicine297
- Public Health, Environmental and Occupational Health252
- Cardiology and Cardiovascular Medicine238
- Oncology188
- Infectious Diseases182
- Epidemiology176
- Neurology151
- Endocrinology, Diabetes and Metabolism141
- Radiology, Nuclear Medicine and Imaging138
- Physiology129
- Psychiatry and Mental health123
Show all 42 subfields
- Orthopedics and Sports Medicine95
- Pediatrics, Perinatology and Child Health85
- Dermatology74
- Ophthalmology74
- Hematology71
- Obstetrics and Gynecology61
- Rheumatology58
- Nephrology49
- Reproductive Medicine45
- Complementary and alternative medicine42
- Pharmacology42
- Emergency Medicine36
- Geriatrics and Gerontology36
- Otorhinolaryngology34
- Rehabilitation29
- Pathology and Forensic Medicine23
- Critical Care and Intensive Care Medicine22
- Genetics19
- Hepatology19
- Immunology and Allergy17
- Anesthesiology and Pain Medicine12
- Urology11
- Gastroenterology6
- Internal Medicine5
- Family Practice3
- Transplantation3
- Health Informatics1
- Anatomy0
- Biochemistry0
- Microbiology0
297 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2014. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2012–2014, the window the 2015 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2012–2014 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2006 to 2015. | Compare |
|---|---|---|---|---|---|---|---|
1European UrologyElsevier BV · Switzerland | 4.61Q1 | 10.59 0.20 down from 2014 | 1,095 | 19% | $5,250 | ||
2Cochrane Database of Systematic ReviewsElsevier BV · United Kingdom | 4.50Q1 | 8.54no change | 2,769 | 62% | $5,100 | ||
3The Lancet Respiratory MedicineElsevier BV · Netherlands | 4.01Q1 | 8.13 2.04 up from 2014 | 344 | 42% | $7,280 | ||
4American Journal of Respiratory and Critical Care MedicineAmerican Thoracic Society · United States | 3.53Q1 | 7.24 1.21 down from 2014 | 1,635 | 40% | — | ||
5Modern PathologyElsevier BV · United States | 2.90Q1 | 6.07 0.34 down from 2014 | 556 | 99% | $4,480 | ||
6Seminars in Fetal and Neonatal MedicineElsevier BV · Netherlands | 2.87Q1 | 4.31 0.28 down from 2014 | 168 | 14% | $4,590 | ||
7Intensive Care MedicineSpringer Science+Business Media · Germany | 2.80Q1 | 7.04 0.21 up from 2014 | 1,030 | 50% | $5,190 | ||
8CHEST JournalElsevier BV · United States | 2.67Q1 | 4.30 1.90 down from 2014 | 2,144 | 31% | $4,160 | ||
9DrugsAdis, Springer Healthcare · New Zealand | 2.64Q1 | 6.51 0.52 up from 2014 | 464 | 20% | $5,990 | ||
10Fibrogenesis & Tissue RepairBioMed Central · United Kingdom | 2.59Q1 | 6.73 0.96 up from 2014 | 82 | 100% | — | ||
11European Respiratory ReviewOAEuropean Respiratory Society · United Kingdom | 2.46Q1 | 4.65 1.03 down from 2014 | 198 | 100% | — | ||
12Seminars in PerinatologyElsevier BV · United States | 2.40Q1 | 3.63 0.69 down from 2014 | 206 | 21% | $4,370 | ||
13RespirationKarger Publishers · Switzerland | 2.33Q1 | 6.59 2.69 up from 2014 | 404 | 30% | — | ||
14European Respiratory JournalEuropean Respiratory Society | 2.32Q1 | 5.15 0.17 down from 2014 | 1,468 | 86% | — | ||
15Annals of Intensive CareOASpringer Nature · France | 2.30Q1 | 5.75 0.81 up from 2014 | 150 | 100% | $3,490 | ||
16The Journal of UrologyLippincott Williams & Wilkins · United States | 2.25Q1 | 4.46 0.22 down from 2014 | 2,260 | 7% | $3,000 | ||
17Radiotherapy and OncologyElsevier BV · Netherlands | 2.17Q1 | 5.65 0.50 up from 2014 | 878 | 80% | $3,770 | ||
18Journal of Thoracic OncologyElsevier BV · United States | 2.06Q1 | 4.67 0.51 down from 2014 | 932 | 89% | $4,100 | ||
19Respiratory ResearchOABioMed Central · United Kingdom | 2.05Q1 | 5.03 0.72 up from 2014 | 422 | 100% | $3,490 | ||
20Therapeutic Advances in Chronic DiseaseOASAGE Publishing · United Kingdom | 2.04Q1 | 5.18 1.32 up from 2014 | 62 | 100% | $2,950 | ||
21ThoraxBMJ · United Kingdom | 2.01Q1 | 4.24 0.27 down from 2014 | 973 | 95% | — | ||
22Current Opinion in Critical CareLippincott Williams & Wilkins · United States | 2.01Q1 | 3.98 0.32 up from 2014 | 277 | 18% | — | ||
23Clinics in Chest MedicineElsevier BV · United States | 1.97Q1 | 4.20 0.63 up from 2014 | 190 | 7% | $3,350 | ||
24International Journal of Radiation Oncology*Biology*PhysicsElsevier BV · United States | 1.94Q1 | 4.55 0.35 up from 2014 | 1,832 | 53% | $4,130 | ||
25Gastrointestinal EndoscopyElsevier BV · United States | 1.93Q1 | 4.51 0.18 up from 2014 | 1,160 | 11% | $3,450 | ||
26Radiologic Clinics of North AmericaElsevier BV · United States | 1.92Q1 | 3.31 0.01 up from 2014 | 210 | 4% | $3,000 | ||
27International Journal of COPDOADove Medical Press · New Zealand | 1.90Q1 | 4.48 0.32 up from 2014 | 294 | 100% | $2,836 | ||
28British Journal of UrologyWiley · United Kingdom | 1.85Q1 | 3.78 0.07 up from 2014 | 1,738 | 36% | $4,770 | ||
29Current Opinion in Pulmonary MedicineLippincott Williams & Wilkins · United States | 1.84Q1 | 4.26 0.58 up from 2014 | 274 | 13% | — | ||
30American Journal of Physiology-Lung Cellular and Molecular PhysiologyAmerican Physical Society · United States | 1.83Q1 | 5.33 0.67 up from 2014 | 623 | 72% | — | ||
31Journal of Hepato-Biliary-Pancreatic SciencesWiley · Japan | 1.83Q1 | 3.94 0.02 up from 2014 | 302 | 47% | $3,700 | ||
32Annals of the American Thoracic SocietyAmerican Thoracic Society · United States | 1.81Q1 | 3.58 0.83 up from 2014 | 478 | 42% | — | ||
33Journal of Cystic FibrosisElsevier BV · Netherlands | 1.81Q1 | 3.69 0.09 up from 2014 | 379 | 100% | $4,370 | ||
34Genes Chromosomes and CancerWiley · United States | 1.79Q1 | 4.65 0.27 up from 2014 | 307 | 23% | $4,810 | ||
35Advances in Anatomic PathologyLippincott Williams & Wilkins · United States | 1.77Q1 | 4.38 0.30 up from 2014 | 133 | 10% | — | ||
36Occupational and Environmental MedicineBMJ · United Kingdom | 1.77Q1 | 3.53 0.14 up from 2014 | 482 | 50% | — | ||
37American Journal of Respiratory Cell and Molecular BiologyAmerican Thoracic Society · United States | 1.77Q1 | 4.31 0.10 down from 2014 | 638 | 69% | — | ||
38Lung CancerElsevier BV · Netherlands | 1.76Q1 | 4.49 0.25 up from 2014 | 775 | 14% | $3,390 | ||
39The ProstateWiley · United States | 1.76Q1 | 4.20 0.01 up from 2014 | 443 | 34% | $4,600 | ||
40Seminars in Respiratory and Critical Care MedicineThieme Medical Publishers (Germany) · United States | 1.75Q1 | 3.56 0.39 down from 2014 | 231 | 30% | — | ||
41Respiratory MedicineElsevier BV · United Kingdom | 1.73Q1 | 4.06 0.25 up from 2014 | 703 | 72% | $3,630 | ||
42Journal of Vascular SurgeryElsevier BV · United States | 1.68Q1 | 3.56 0.35 up from 2014 | 1,690 | 100% | $4,010 | ||
43Gastric CancerSpringer Science+Business Media · Japan | 1.64Q1 | 3.95 0.93 up from 2014 | 323 | 78% | $3,590 | ||
44Clinical Sarcoma ResearchOASpringer Science+Business Media · United Kingdom | 1.62Q1 | 2.81 0.58 down from 2014 | 57 | 100% | $2,290 | ||
45Core evidenceOADove Medical Press · New Zealand | 1.61Q1 | 4.63 0.21 up from 2014 | 31 | 100% | — | ||
46Advances in TherapyAdis, Springer Healthcare · United Kingdom | 1.61Q1 | 3.55 0.42 up from 2014 | 245 | 71% | $4,790 | ||
47Urologic Clinics of North AmericaElsevier BV · United States | 1.61Q1 | 2.88 0.51 up from 2014 | 156 | 12% | $3,000 | ||
48Prostate Cancer and Prostatic DiseasesSpringer Nature · United Kingdom | 1.59Q1 | 4.18 0.29 down from 2014 | 161 | 39% | $5,190 | ||
49CoughBioMed Central · United Kingdom | 1.57Q1 | 3.09 0.42 up from 2014 | 46 | — | — | ||
50Therapeutic Advances in UrologyOASAGE Publishing · United Kingdom | 1.56Q1 | 3.51 0.74 up from 2014 | 89 | 100% | $2,650 |
Subfields of Medicine, with Pulmonary and Respiratory Medicine highlighted.
- Surgery773
- Pulmonary and Respiratory Medicine297
- Public Health, Environmental and Occupational Health252
- Cardiology and Cardiovascular Medicine238
- Oncology188
- Infectious Diseases182
- Epidemiology176
- Neurology151
- Endocrinology, Diabetes and Metabolism141
- Radiology, Nuclear Medicine and Imaging138
- Physiology129
- Psychiatry and Mental health123
- Orthopedics and Sports Medicine95
- Pediatrics, Perinatology and Child Health85
- Dermatology74
- Ophthalmology74
- Hematology71
- Obstetrics and Gynecology61
- Rheumatology58
- Nephrology49
- Reproductive Medicine45
- Complementary and alternative medicine42
- Pharmacology42
- Emergency Medicine36
- Geriatrics and Gerontology36
- Otorhinolaryngology34
- Rehabilitation29
- Pathology and Forensic Medicine23
- Critical Care and Intensive Care Medicine22
- Genetics19
- Hepatology19
- Immunology and Allergy17
- Anesthesiology and Pain Medicine12
- Urology11
- Gastroenterology6
- Internal Medicine5
- Family Practice3
- Transplantation3
- Health Informatics1
- Anatomy0
- Biochemistry0
- Microbiology0
Journals
Citations made in 2015. Corpus-wide, 78.1% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
109 additional Pulmonary and Respiratory Medicine journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2012–2014, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2015. Publication window: 2012–2014. How these summaries are calculated
- Ranked journals
- 297
- Window papers (baseline)
- 152,077 +12.6% from indicator year 2012
- Median OJR
- 0.731 -12.7% from indicator year 2012
- Rising journals (2025)
- 26
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2012–2014 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 116 | 128 | 133 | 140 | 152 | 172 | 181 | 194 | 199 | 212 | 221 | 236 | 245 | 266 | 283 | 297 | 315 | 324 | 349 | 347 | 353 | 362 | 367 | 367 | 364 | 352 | |
| Window papers (baseline) | 51,191 | 58,101 | 61,730 | 66,053 | 67,282 | 74,504 | 82,746 | 93,558 | 102,120 | 113,728 | 123,057 | 131,093 | 135,018 | 138,763 | 146,389 | 152,077 | 157,160 | 158,971 | 164,168 | 168,770 | 175,931 | 189,625 | 206,647 | 218,275 | 218,995 | 219,470 | |
| Median OJR | 0.56 | 0.57 | 0.55 | 0.628 | 0.671 | 0.663 | 0.713 | 0.664 | 0.693 | 0.70 | 0.767 | 0.80 | 0.84 | 0.768 | 0.75 | 0.731 | 0.689 | 0.6662 | 0.68 | 0.710 | 0.730 | 0.6663 | 0.665 | 0.687 | 0.64 | 0.633 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.